A proteomic study on a human osteosarcoma cell line Saos-2 treated with diallyl trisulfide

YK Zhang, XH Zhang, JM Li, Q Yang, DM Diao - Anti-cancer …, 2009 - journals.lww.com
Garlic is generally used as a therapeutic reagent against various diseases, and numerous
studies have indicated that garlic and its derivatives can reduce the risk of various types of …

Endothelin-1 (ET-1) induces resistance to bortezomib in human multiple myeloma cells via a pathway involving the ETB receptor and upregulation of proteasomal …

M Vaiou, E Pangou, P Liakos, N Sakellaridis… - Journal of cancer …, 2016 - Springer
Purpose Bortezomib (BTZ) is used for the treatment of multiple myeloma (MM). However, a
significant proportion of patients may be refractory to the drug. This study aimed to …

VDR agonists down regulate PI3K/Akt/mTOR axis and trigger autophagy in Kaposi's sarcoma cells

A Suares, C Tapia, V González-Pardo - Heliyon, 2019 - cell.com
The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor (KSHV/vGPCR) is
a key molecule in the pathogenesis of Kaposi's sarcoma. We have previously shown that 1α …

Proteasome inhibition reduces proliferation, collagen expression, and inflammatory cytokine production in nasal mucosa and polyp fibroblasts

L Pujols, L Fernández-Bertolín, M Fuentes-Prado… - … of Pharmacology and …, 2012 - ASPET
Proteasome inhibitors, used in cancer treatment for their proapoptotic effects, have anti-
inflammatory and antifibrotic effects on animal models of various inflammatory and fibrotic …

Proteasome inhibition induces IKK-dependent interleukin-8 expression in triple negative breast cancer cells: Opportunity for combination therapy

MM Uddin, Y Zou, T Sharma, HR Gatla, I Vancurova - PloS one, 2018 - journals.plos.org
Triple negative breast cancer (TNBC) cells express increased levels of the pro-inflammatory
and pro-angiogenic chemokine interleukin-8 (IL-8, CXCL8), which promotes their …

Linking the activity of bortezomib in multiple myeloma and autoimmune diseases

Z Škrott, B Cvek - Critical reviews in oncology/hematology, 2014 - Elsevier
Since their introduction to the clinic 10 years ago, proteasome inhibitors have become the
cornerstone of anti-multiple myeloma therapy. Despite significant progress in understanding …

Proteasome inhibition protects against diet-induced gallstone formation through modulation of cholesterol and bile acid homeostasis

EJ Lee, MH Kim, YR Kim… - … journal of molecular …, 2018 - spandidos-publications.com
Gallstone disease is one of the most prevalent and costly gastrointestinal disorders
worldwide. Gallstones are formed in the biliary system by cholesterol secretions in bile …

Proteasome inhibitors suppress ErbB family expression through HSP90-mediated lysosomal degradation

TK Huynh, CY Ho, CH Tsai, CK Wang, YJ Chen… - International journal of …, 2019 - mdpi.com
Although dual EGFR/HER2 tyrosine kinase inhibitor lapatinib has provided effective clinical
benefits for HER2-positive breast cancer patients, acquired resistance to this drug remains a …

Boron compounds in the breast cancer cells chemoprevention and chemotherapy

IR Scorei - Breast Cancer-Current and Alternative Therapeutic …, 2011 - books.google.com
Various biological functions of Boron (B) compounds are known (Blevins & Lukaszewski,
1994; Tariq & Mott, 2007; Nielsen, 2008). Boron is found in nuts, vegetables, dried/fresh …

[HTML][HTML] Antitumor activity of efrapeptins, alone or in combination with 2-deoxyglucose, in breast cancer in vitro and in vivo

AE Papathanassiu, NJ MacDonald, DR Emlet… - Cell Stress and …, 2011 - Elsevier
Efrapeptins (EF), a family of fungal peptides, inhibit proteasomal enzymatic activities and the
in vitro and in vivo growth of HT-29 cells. They are also known inhibitors of F 1 F 0-ATPase …